Bernard Roubert
Overview
Explore the profile of Bernard Roubert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
1377
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jin J, Ran Z, Noseda E, Roubert B, Marty M, Mezzacasa A, et al.
Front Med
. 2023 Oct;
18(1):98-108.
PMID: 37897561
Iron deficiency (ID) and ID anemia (IDA) pose significant public health concerns in China. Although iron sucrose (IS) treatment is well-established in the country, ferric carboxymaltose (FCM) offers the advantage...
2.
Ponikowski P, Mentz R, Hernandez A, Butler J, Khan M, Van Veldhuisen D, et al.
Eur Heart J
. 2023 Aug;
44(48):5077-5091.
PMID: 37632415
Background And Aims: Whereas a beneficial effect of intravenous ferric carboxymaltose (FCM) on symptoms and exercise capacity among patients with iron deficiency and heart failure (HF) has been consistently demonstrated,...
3.
Khan M, Anker S, Friede T, Jankowska E, Metra M, Pina I, et al.
J Card Fail
. 2022 Nov;
29(5):760-770.
PMID: 36332897
Background: The 6-minute walk test (6MWT) is widely used to measure exercise capacity; however, the magnitude of change that is clinically meaningful for individuals is not well established in heart...
4.
Butler J, Khan M, Mori C, Filippatos G, Ponikowski P, Comin-Colet J, et al.
Eur J Heart Fail
. 2020 Apr;
22(6):999-1005.
PMID: 32239794
Aims: While the associations of health-related quality of life scores in heart failure (HF) [e.g. the Kansas City Cardiomyopathy Questionnaire (KCCQ)] with clinical outcomes are well established, their interpretation in...
5.
Ding Y, Zhu X, Li X, Zhang H, Wu M, Liu J, et al.
Clin Ther
. 2020 Jan;
42(2):276-285.
PMID: 31937462
Purpose: Iron deficiency (ID) is one of the most commonly known nutritional deficiencies and is considered the primary cause of anemia (iron-deficiency anemia). Ferric carboxymaltose (FCM), an intravenous iron preparation,...
6.
Richard F, Van Lier J, Roubert B, Haboubi T, Gohring U, Durrenberger F
Am J Hematol
. 2019 Nov;
95(1):68-77.
PMID: 31674058
Restriction of iron availability by ferroportin inhibition is a novel approach to treating non-transfusion-dependent thalassemia (β-thalassemia intermedia). This first-in-human, Phase I study (https://www.clinicaltrialsregister.eu; EudraCT no. 2017-003395-31) assessed the safety, tolerability,...
7.
Ponikowski P, Van Veldhuisen D, Comin-Colet J, Ertl G, Komajda M, Mareev V, et al.
ESC Heart Fail
. 2017 Aug;
1(1):52-58.
PMID: 28834668
Background: Iron deficiency (ID) is a common co-morbidity associated with chronic heart failure (CHF), which has unfavourable clinical and prognostic consequences. In Ferinject Assessment in Patients with IRon Deficiency and...
8.
Van Veldhuisen D, Ponikowski P, van der Meer P, Metra M, Bohm M, Doletsky A, et al.
Circulation
. 2017 Jul;
136(15):1374-1383.
PMID: 28701470
Background: Iron deficiency is common in patients with heart failure (HF) and is associated with reduced exercise capacity and poor outcomes. Whether correction of iron deficiency with (intravenous) ferric carboxymaltose...
9.
Trenkwalder C, Winkelmann J, Oertel W, Virgin G, Roubert B, Mezzacasa A
Mov Disord
. 2017 Jun;
32(10):1478-1482.
PMID: 28643901
Background: Compromised iron status is important in restless legs syndrome pathophysiology. We compared the efficacy and tolerability of ferric carboxymaltose (single intravenous dose) versus placebo for restless legs syndrome treatment...
10.
Anker S, Kirwan B, Van Veldhuisen D, Filippatos G, Comin-Colet J, Ruschitzka F, et al.
Eur J Heart Fail
. 2017 Apr;
20(1):125-133.
PMID: 28436136
Aims: Iron deficiency (ID) is a common co-morbidity in patients with heart failure (HF) and has been suggested to be associated with poor prognosis. Recently completed double-blind randomised controlled trials...